Mediware's HCLL Blood Management Suite Continues Market Share Gains With Key Client Win

Mediware Licenses HCLL Transfusion Software to Support Blood Management at Select Tenet Hospitals in Florida


LENEXA, Kan., Oct. 18, 2006 (PRIMEZONE) -- Mediware Information Systems (Nasdaq:MEDW) announced that a subsidiary of Tenet Healthcare Corporation has licensed Mediware's HCLL Transfusion software to support blood bank services in four of its acute care hospitals in Florida. Financial terms of the agreement were not disclosed.

Tenet Healthcare Corporation (NYSE:THC) is based in Dallas, Texas, and through its subsidiaries, owns and operates 66 acute care hospitals in 12 states. The facilities included in this license represent more than 1500 beds in South Florida and will enable blood bank staff across the state to implement robust processes that improve efficiencies, decrease waste and increase patient safety. The four facilities include:



 -- Florida Medical Center, part of Tenet's Miami-Dade/Broward
    Health Network, is a 459-bed acute care hospital located in
    Fort Lauderdale.  The medical center is a center of excellence
    for cardiology and bariatrics and offers a variety of services,
    including orthopedics, neurology, urology, a dedicated stroke
    center and a new women's health center.

 -- North Ridge Medical Center, a 332-bed acute care hospital in
    Fort Lauderdale, has been providing services through its
    Cardiac & Vascular Institute for over 30 years.  North Ridge
    Medical Center also offers a wide array of award-winning care
    focusing on medical, surgical, orthopedic and neurosurgery.

 -- Good Samaritan Medical Center, in West Palm Beach, FL, is a
    333-bed acute care facility that is celebrating its
    85th Anniversary of providing healthcare to the region.

 -- St. Mary's Medical Center, also located in West Palm Beach, is
    a 460-bed acute care hospital offering medical, surgical,
    obstetrical, pediatric, orthopedic and emergency services.

HCLL(tm) Transfusion software is a next-generation transfusion management system and a key component of Mediware's blood management suite. HCLL manages blood products administered to patients at hospitals and centralized transfusion service facilities and automates processes to improve efficiencies and decrease waste. HCLL(tm) Transfusion, commercially available since 2003, is widely recognized as a powerful patient safety tool and continues to see adoption by leading healthcare facilities throughout the world.

"Mediware considers each and every client to be a partner in the effort to bring increased safety and efficiency to the care process," said John Damgaard, vice president and general manager of Mediware's Blood Management division. "We are very pleased that Tenet chose to build upon our relationship by adopting our next-generation transfusion management system."

About Mediware

Mediware delivers powerful software solutions that encapsulate patient care instructions, reinforce patient safety practices and improve efficiencies to lower costs. Mediware targets three primary areas of patient care -- Medication Management, Perioperative management and Blood transfusion, inventory and donor practices -- with specialized solutions that are proven in more than 1,000 client installations. Mediware's customers include prestigious hospitals, clinics, correctional institutions, blood centers and other public and private health care institutions throughout the world. For more information about Mediware products and services, visit our web site at www.mediware.com.

Certain statements in this press release may constitute "forward-looking'' statements within the meaning of the Private Securities Litigation Reform Act of 1995, as the same may be amended from time to time (the "Act'') and in releases made by the SEC from time to time. Such forward-looking statements are not based on historical facts and involve known and unknown risks, uncertainties and other factors disclosed in the Company's Annual Report on Form 10-K for the year ended June 30, 2006, which may cause the actual results of the Company to be materially different from any future results expressed or implied by such forward-looking statements. The Company disclaims any obligation to update its forward-looking statements.



            

Contact Data